Guided Therapeutics, Inc. Sustainability Profile
Guided Therapeutics, Inc., often referred to as Guided Therapeutics, is a pioneering company headquartered in the United States, specialising in advanced medical technologies. Founded in 2006, the company has made significant strides in the field of non-invasive diagnostic solutions, particularly for the early detection of cancer. Guided Therapeutics is renowned for its innovative LuViva® Advanced Cervical Scan, which utilises cutting-edge technology to provide real-time, accurate assessments of cervical health. This unique approach not only enhances patient outcomes but also positions the company as a leader in the women's health sector. With a commitment to improving diagnostic accuracy, Guided Therapeutics continues to expand its operational reach, solidifying its market position through strategic partnerships and ongoing research initiatives.
DitchCarbon Score
How does Guided Therapeutics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Guided Therapeutics, Inc.'s score of 23 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Guided Therapeutics, Inc.'s reported carbon emissions
Guided Therapeutics, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or commitments to climate initiatives, such as those outlined by the Science Based Targets initiative (SBTi). As a result, there are no significant achievements or targets to highlight regarding their carbon footprint or climate commitments. The lack of emissions data and reduction initiatives suggests that Guided Therapeutics, Inc. may still be in the early stages of developing a comprehensive climate strategy. In the context of the industry, it is increasingly important for companies to adopt transparent climate commitments and set measurable targets to align with global sustainability goals.
How Carbon Intensive is Guided Therapeutics, Inc.'s Industry?
How Carbon Intensive is Guided Therapeutics, Inc.'s Location?
Guided Therapeutics, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Guided Therapeutics, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
